Hims & Hers Health Inc (NYSE: HIMS) started the day on Wednesday, with a price decrease of -9.94% at $33.36, before settling in for the price of $37.04 at the close. Taking a more long-term approach, HIMS posted a 52-week range of $11.20-$72.98.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Consumer Defensive sector firm’s twelve-monthly sales growth has been 62.28% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 17.22%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 12.77%. This publicly-traded company’s shares outstanding now amounts to $212.46 million, simultaneously with a float of $181.97 million. The organization now has a market capitalization sitting at $7.41 billion. At the time of writing, stock’s 50-day Moving Average stood at $39.09, while the 200-day Moving Average is $26.03.
Hims & Hers Health Inc (HIMS) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Household & Personal Products Industry. Hims & Hers Health Inc’s current insider ownership accounts for 18.09%, in contrast to 73.60% institutional ownership. Preceding that transaction, on Mar 21 ’25, Company’s Chief Financial Officer sold 23,118 for 32.41, making the whole transaction’s value amount to 749,176. This particular insider is now the holder of 129,248 in total.
Hims & Hers Health Inc (HIMS) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.24 per share during the current fiscal year.
Hims & Hers Health Inc’s EPS increase for this current 12-month fiscal period is 12.77% and is forecasted to reach 0.86 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 31.05% through the next 5 years, which can be compared against the 17.22% growth it accomplished over the previous five years trading on the market.
Hims & Hers Health Inc (NYSE: HIMS) Trading Performance Indicators
Let’s observe the current performance indicators for Hims & Hers Health Inc (HIMS). It’s Quick Ratio in the last reported quarter now stands at 1.50. The Stock has managed to achieve an average true range (ATR) of 4.37. Alongside those numbers, its PE Ratio stands at $62.38, and its Beta score is 1.56. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.02. Similarly, its price to free cash flow for trailing twelve months is now 37.37.
In the same vein, HIMS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.53, a figure that is expected to reach 0.11 in the next quarter, and analysts are predicting that it will be 0.86 at the market close of one year from today.
Technical Analysis of Hims & Hers Health Inc (HIMS)
If we take a close look at the recent performances of Hims & Hers Health Inc (NYSE: HIMS), its last 5-days Average volume was 25.36 million that shows progress from its year to date volume of 22.61 million. During the previous 9 days, stock’s Stochastic %D was recorded 66.08% While, its Average True Range was 4.02.
Raw Stochastic average of Hims & Hers Health Inc (HIMS) in the period of the previous 100 days is set at 27.51%, which indicates a major fall in contrast to 30.60% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 94.21% that was lower than 132.89% volatility it exhibited in the past 100-days period.
